Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6957)
All Articles published online
|
Publishing Process of This Article
|
Oct 6, 2020 (publication date) through Dec 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li B, Li GW, Xue L, Chen YY. Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: A case report. World J Clin Cases 2020; 8(19): 4527-4534 [PMID: 33083414 DOI: 10.12998/wjcc.v8.i19.4527] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i19/4527.htm |
| Number | Citing Articles |
| 1 |
Jianqiu Yang, Chunyu Yuan, Shengru Zhou, Zhicheng Teng, Min Li. Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome with Baricitinib, a Janus Kinase Inhibitor. Clinical, Cosmetic and Investigational Dermatology 2024; : 529 doi: 10.2147/CCID.S446468
|
| 2 |
Qiong Sun, Qinchen Gu, Haixu Jiang, Weizhong Li, Zhimin Lin, Chen Li, Zhenhua Ying. Is JAK effective in treating recurrent SAPHO syndrome? TwHF might be a good choice. Medicine 2024; 103(29): e38848 doi: 10.1097/MD.0000000000038848
|
| 3 |
Fangfang Yuan, Jing Luo, Qiong Yang. SAPHO Syndrome Complicated by Ankylosing Spondylitis Successfully Treated With Tofacitinib: A Case Report. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.911922
|
| 4 |
Dan-dan Ruan, Ruo-li Wang, Ya-nan Hu, Xing Lin, Jie-wei Luo, Qing-hua Yu, Jia-bin Wu. Clinical and imaging features of six Han patients with SAPHO syndrome. Acta Radiologica 2024; 65(2): 211 doi: 10.1177/02841851221142783
|
| 5 |
Yan‐hong Sun, Xiao‐yong Man, Xiu‐yun Xuan, Chang‐zheng Huang, Ying Shen, Li‐min Lao. Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: A retrospective case series. Dermatologic Therapy 2022; 35(11) doi: 10.1111/dth.15848
|
| 6 |
|
| 7 |
Wei Cheng, Fen Li, Jing Tian, Xi Xie, Jin-Wei Chen, Xiao-Fei Peng, Qi Tang, Yan Ge. New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations. Journal of Inflammation Research 2022; : 2365 doi: 10.2147/JIR.S353539
|
| 8 |
Ritasman Baisya, Meghna Gavali, Mudit Tyagi, Phani Kumar Devarasetti, Gregory J. Tsay. A Case of SAPHO Syndrome Complicated by Uveitis with Good Response to Both TNF Inhibitor and JAKinib. Case Reports in Rheumatology 2023; 2023: 1 doi: 10.1155/2023/6201887
|
| 9 |
Qingyun Yue, Mingwei Ma, Shengyan Liu, Yuanhao Wu, Chen Li. JAKi: Can it be used to treat SAPHO syndrome?. International Journal of Rheumatic Diseases 2024; 27(1) doi: 10.1111/1756-185X.14930
|
| 10 |
Sezgi Sarikaya Solak, Hande Yelgen Ilyas. Tofacitinib: a successful treatment option for SAPHO syndrome. International Journal of Dermatology 2024; 63(5): 671 doi: 10.1111/ijd.17075
|
| 11 |
Andrea Skrabl-Baumgartner. Chronisch nicht bakterielle Osteomyelitis im Kindesalter. rheuma plus 2024; 23(3): 170 doi: 10.1007/s12688-023-00693-w
|
| 12 |
Yiming Fan, Rui Yin. Janus kinase inhibitor tofacitinib successfully treated palmoplantar pustulosis after switching from secukinumab: A case report and review of the literature. International Immunopharmacology 2024; 139: 112762 doi: 10.1016/j.intimp.2024.112762
|